REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Cristiam Gram I.P.S S.A.S. (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio Clinico Cristiam Gram I.P.S S.A.S. Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Clinico Cristiam Gram I.P.S S.A.S. is an enterprise located in Colombia, with the main office in Valledupar. The company operates in the Diagnostic Imaging Centers sector. It was first established on August 05, 2010. 17 (2017) employees currently work for Laboratorio Clinico Cristiam Gram I.P.S S.A.S.. The latest financial highlights indicate a net sales revenue drop of 54.06% in 2023. Its’ total assets recorded a negative growth of 10.91%. The net profit margin of Laboratorio Clinico Cristiam Gram I.P.S S.A.S. decreased by 2.92% in 2023.

Headquarters
Tv 18 20 94 Lc 110 Edificio Centro Medi
Valledupar; Cesar;

Contact Details: Purchase the Laboratorio Clinico Cristiam Gram I.P.S S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Clinico Cristiam Gram I.P.S S.A.S. report to view the information.
Outstanding Shares:
Purchase the Laboratorio Clinico Cristiam Gram I.P.S S.A.S. report to view the information.
Incorporation Date:
August 05, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Clinico Cristiam Gram I.P.S S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-54.06%
Total operating revenue
-54.06%
Operating profit (EBIT)
-65.87%
EBITDA
-66.76%
Net Profit (Loss) for the Period
-73.15%
Total assets
-10.91%
Total equity
42.52%
Operating Profit Margin (ROS)
-3.12%
Net Profit Margin
-2.92%
Return on Equity (ROE)
-39.02%
Quick Ratio
0.31%
Cash Ratio
0.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?